Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls
- 1 January 2005
- journal article
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 20 (1), 50-54
- https://doi.org/10.1016/j.eurpsy.2004.09.005
Abstract
Nicotine has been proposed to provide anxiety relief, oral gratification and self-medication of psychotic symptoms in psychiatric patients. In order to investigate the relations between psychopathology and tobacco use we measured the concentration of cotinine, the major metabolite of nicotine, in the saliva of psychiatric patients and healthy volunteers. In a sample of 42 schizophrenic patients we correlated smoking status, cotinine levels, symptom profiles (PANSS), and neuroleptic side effects (Simpson–Angus). Despite reporting the same amount of cigarettes consumed per day the saliva concentration of cotinine was significantly higher in patients with schizophrenia than in the controls. There were no significant differences in clinical characteristics between smoking and non-smoking schizophrenic patients, but smokers tended to be on higher drug doses. High cotinine concentrations correlated significantly with the negative symptoms Passive withdrawal and Social avoidance. The results indicate that the schizophrenic patients smoke cigarettes more intensely than other patients and healthy subjects. The correlation between high cotinine levels and negative symptomatology may reflect an attempt by schizophrenic patients to overcome the emotional withdrawal and thus the results may lend support to a self-medication hypothesis.Keywords
This publication has 27 references indexed in Scilit:
- The influence of cigarette consumption and smoking machine yields of tar and nicotine on the nicotine uptake and oral mucosal lesions in smokersJournal of Oral Pathology & Medicine, 1997
- Effect of smoking on neuroleptics in schizophreniaSchizophrenia Research, 1997
- Is Serum Cotinine a Better Measure of Cigarette-Smoking Than Self-Report?Preventive Medicine, 1995
- Nicotine Dependence, Midbrain Dopamine Systems and Psychiatric DisordersBasic & Clinical Pharmacology & Toxicology, 1995
- Cigarette Smoking: Effects on Cognitive Functions and Drug-Induced Parkinsonism in Chronic SchizophreniaInternational Journal of Neuroscience, 1993
- The Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophreniaActa Psychiatrica Scandinavica, 1992
- Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels.American Journal of Public Health, 1992
- A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluidsJournal of Pharmacy and Pharmacology, 1990
- Does Smoking Reduce the Risk of Neuroleptic Parkinsonoids?Pharmacopsychiatry, 1988
- Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neuronsBrain Research, 1985